Long-Acting Antidepressants: Recommended Agents and Dosing
For long-acting antidepressant therapy, fluoxetine stands out as the only SSRI with a very long half-life (allowing every-other-day dosing), while extended-release formulations of venlafaxine, bupropion, and mirtazapine provide once-daily dosing with improved tolerability compared to immediate-release preparations.
Primary Long-Acting Options
Fluoxetine (Prozac)
- Starting dose: 10 mg every other morning 1
- Target dose: 20 mg every morning 1
- Key characteristics: Very long half-life makes it the most "forgiving" SSRI for missed doses; activating properties; side effects may not manifest for several weeks due to prolonged half-life 1
- Titration: Can increase at 3-4 week intervals due to long half-life 2
Venlafaxine Extended-Release
- Starting dose: 37.5 mg once or twice daily 3
- Titration: Increase by 75 mg each week 3
- Target dose: 150-225 mg/day 3
- Maximum: 225 mg/day 3
- Duration for adequate trial: 4-6 weeks 3
- Caution: Requires tapering when discontinuing due to withdrawal syndrome; use cautiously in cardiac disease due to potential blood pressure increases and conduction abnormalities 3
Bupropion Extended-Release
- Starting dose: 37.5 mg every morning 1
- Titration: Increase by 37.5 mg every 3 days 1
- Target dose: 150 mg twice daily 1
- Maximum: 400 mg/day for sustained-release formulation 4
- Key characteristics: Activating; no serotonergic effects; useful for patients with sexual dysfunction from other antidepressants; contraindicated in seizure disorders and agitated patients 1, 4
- Timing: Give second dose before 3 PM to minimize insomnia 1
Mirtazapine
- Starting dose: 7.5 mg at bedtime 1
- Target dose: 30 mg at bedtime 1
- Maximum: 45 mg at bedtime 5
- Titration: Can increase every 1-2 weeks due to long half-life 4
- Key characteristics: Sedating; promotes sleep, appetite, and weight gain; well tolerated; onset of action within 1-2 weeks 1, 4
Alternative Long-Acting SSRI Options
Sertraline (Zoloft)
- Starting dose: 25-50 mg per day 1
- Target dose: 50 mg daily (optimal dose for most patients) 6, 7
- Maximum: 200 mg per day 1
- Titration: Increase at 1-2 week intervals 2
- Key characteristics: Well tolerated; less effect on drug metabolism compared to other SSRIs; 50 mg is usually the effective therapeutic dose without need for titration 6, 8
Citalopram (Celexa)
- Starting dose: 10 mg per day 1
- Maximum: 40 mg per day 1
- Titration: Increase at 1-2 week intervals 2
- Critical warning: Do NOT exceed 40 mg/day due to QT prolongation risk and potential for Torsade de Pointes 2
- Key characteristics: Well tolerated; least effect on CYP450 enzymes; lower drug interaction potential 2
Escitalopram (Lexapro)
- Starting dose: 10 mg per day 9
- Target dose: 10-20 mg per day
- Key characteristics: Preferred in elderly patients; well tolerated 9
Critical Prescribing Considerations
Titration Strategy
- Start low in elderly patients and titrate more slowly 3
- Adequate trial duration: 4-8 weeks minimum, with at least 2 weeks at maximum tolerated dose 1
- Monitor response: Assess within 1-2 weeks of initiation, then regularly 10
- Modify treatment if inadequate response after 6-8 weeks 10
Common Pitfall
Most patients in clinical practice never receive the dose required for maximum antidepressant effect 11. For example, 54% of patients under 65 and 79% of patients over 65 never received doses shown to exert maximum efficacy (>20 mg citalopram, >10 mg escitalopram, >50 mg sertraline) 11. Don't undertitrate—push to effective doses unless limited by tolerability.
Discontinuation
- Taper over 10-14 days to limit withdrawal symptoms 1
- Paroxetine, fluvoxamine, sertraline, and venlafaxine have higher risk of discontinuation syndrome 2
- Fluoxetine requires minimal tapering due to long half-life
Special Populations
Elderly patients: Prefer citalopram, escitalopram, sertraline, mirtazapine, venlafaxine, or bupropion; avoid paroxetine and fluoxetine due to higher adverse effect rates 9